Gila Gabay

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a Randomized Controlled Trial

Timna Naftali, Refael Mechulam, Amir Marii et al. · Digestive Diseases and Sciences · 2017 · 206 citations

Gastrointestinal Pharmacology, Medicine, Gastroenterology +4

Interactions between the intestinal microbiota and bile acids in gallstones patients

Nirit Keren, Fred M. Konikoff, Yossi Paitan et al. · Environmental Microbiology Reports · 2015 · 181 citations

Dysbiosis, Gastroenterology, Pathology +19

High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance

R. Towers, Timna Naftali, Gila Gabay et al. · Clinical & Experimental Immunology · 2005 · 52 citations · Full text

Helicobacter pylori: the Middle East scenario.

Ben Novis, Gila Gabay, Timna Naftali · PubMed · 1999 · 38 citations

Saudi Arabia, Global Health, Helicobacter Pylori +13

Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease

Doron Yablecovitch, Assaf Stein, Maytal Shabat-Simon et al. · Digestive Diseases and Sciences · 2015 · 27 citations

Inflammation, Chronic Inflammatory Diseases, Mucosal Immunology +7